Japanese Start-Up Biotech To Use New Ways To Find Antibodies
This article was originally published in PharmAsia News
Japan's government laboratory and Chiome Bioscience, a startup associated with it, plan to find a new way to search for antibodies that could be developed into drugs and reagents for diagnostics. The procedure planned involves using magnetic beads to sift a pair of antibody-antigen reactions out of a solution using a magnet. The difference between the plan developed by the joint work of Chiome and the government lab Riken and previous methods is the use of a magnet to separate wanted antibodies from unwanted ones. (Click here for more - a subscription may be required
You may also be interested in...
TransEnterix hires Shameze Rampertab as its new CFO and said it expects “modest growth” in Q3 and Q4.
Keeping Track: Viltepso Earns Priority Review Voucher; Manufacturing Trips Fennec; Eagle Drops Ryanodex Exertional Heat Stroke Bid
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
CureVac raised hundreds of millions of dollars this year before its $213m initial public offering as its mRNA vaccine technology moved into the COVID-19 spotlight. Its stock price tripled on its debut.